摘要
嗜酸性粒细胞是居住在血液和组织包括肺、乳腺、胃肠道和生殖系统中的粒细胞白细胞。在健康个体中,嗜酸性粒细胞增多症是罕见的。然而,它与过敏,寄生虫感染和一些炎症状态有关。在癌症中,嗜酸性粒细胞也被观测,包括结肠癌,乳腺癌,卵巢癌,宫颈癌,口腔癌,霍奇金淋巴瘤和前列腺癌等。嗜酸性粒细胞导致有利或不利的预后仍然存在争议,取决于许多因素,包括癌症的类型增加。嗜酸性粒细胞浸润对霍奇金淋巴瘤是不利的,相反地,它还与结直肠癌预后良好,乳腺癌和前列腺癌有关。嗜酸性粒细胞分泌多种细胞因子和因素,其中包括嗜酸性粒细胞阳离子蛋白,嗜酸性粒细胞神经毒素,过氧化物酶和主要碱性蛋白,它们具有抗肿瘤作用或刺激肿瘤的进展。在此,我们将讨论嗜酸粒细胞在肿瘤免疫中的作用机制,从而解释他们在肿瘤发生时的作用差异。
关键词: 癌;嗜酸性粒细胞;嗜酸性粒细胞癌;预后。
Current Medicinal Chemistry
Title:Eosinophils in Cancer: Favourable or Unfavourable?
Volume: 23 Issue: 7
Author(s): Samy Sakkal, Sarah Miller, Vasso Apostolopoulos, Kulmira Nurgali
Affiliation:
关键词: 癌;嗜酸性粒细胞;嗜酸性粒细胞癌;预后。
摘要: Eosinophils are granulocytic leukocytes residing in blood and tissues in the lung, breast, gastrointestinal and reproductive systems. Eosinophilia is uncommon in healthy individuals, however, it is associated with allergies, helminth infections and some inflammatory states. Eosinophilia has also been observed in cancer, including colorectal, breast, ovarian, cervical, oral squamous, Hodgkin’s lymphoma and prostate cancer. Whether an increase in eosinophils leading to a favourable or unfavourable prognosis still remains controversial and depends on many factors including the type of cancer. Eosinophil infiltration is considered unfavourable in Hodgkin’s lymphoma, conversely it has also been linked to a favourable prognosis in colorectal, breast and prostate cancers. Eosinophils secrete a variety of cytokines and factors including eosinophil cationic protein, eosinophil-derived neurotoxin, peroxidase and major basic protein which have either anti-tumor effects or stimulate tumor progression. Herein, we discuss the role of eosinophils in tumor immunity and propose mechanisms accounting for their functional differences in tumorigenesis.
Export Options
About this article
Cite this article as:
Samy Sakkal, Sarah Miller, Vasso Apostolopoulos, Kulmira Nurgali , Eosinophils in Cancer: Favourable or Unfavourable?, Current Medicinal Chemistry 2016; 23 (7) . https://dx.doi.org/10.2174/0929867323666160119094313
DOI https://dx.doi.org/10.2174/0929867323666160119094313 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prediction of Disease-Related Genes Based on Hybrid Features
Current Proteomics Radiological Assessment of Giant Cell Tumour of Bone in the Sacrum: From Diagnosis to Treatment Response Evaluation
Current Medical Imaging The Role of Vitamin D and Sunlight Incidence in Cancer
Anti-Cancer Agents in Medicinal Chemistry Endometriosis and Gynecological Cancer
Current Women`s Health Reviews Functional Genomics of the Oxidative Stress Pathway
Current Hypertension Reviews Pharmacological Approaches to Targeting Muscarinic Acetylcholine Receptors
Recent Patents on CNS Drug Discovery (Discontinued) The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy
Current Drug Targets Epithelial-Mesenchymal Transitions and Cancer
Current Genomics Incretin-Based Antidiabetic Agents for the Management of Non-Alcoholic Fatty Liver Disease
Current Vascular Pharmacology Radiolabeled Nanoparticles for Cancer Diagnosis and Therapy
Anti-Cancer Agents in Medicinal Chemistry Hydrogen Sulfide Generation in Mammals: The Molecular Biology of Cystathionine-β-Synthase (CBS) and Cystathionine-γ-Lyase (CSE)
Inflammation & Allergy - Drug Targets (Discontinued) Psychiatric Side Effects of Interferon Treatment
Current Drug Safety CARING (CAncer Risk and INsulin analoGues): The Association of Diabetes Mellitus and Cancer Risk with Focus on Possible Determinants - A Systematic Review and a Meta-Analysis
Current Drug Safety Oleamide Derivatives are Prototypical Anti-Metastasis Drugs that Act by Inhibiting Connexin 26
Current Drug Safety Curcumin in Combined Cancer Therapy
Current Pharmaceutical Design Radiolabelled Probes Targeting Tumor Hypoxia for Personalized Medicine
Current Pharmaceutical Design Recent Advances in the Design and Synthesis of c-Met Inhibitors as Anticancer Agents (2014-Present)
Current Medicinal Chemistry It is All About Proteases: From Drug Delivery to In Vivo Imaging and Photomedicine
Current Medicinal Chemistry Gold and Silver Nanoparticles for Applications in Theranostics
Current Topics in Medicinal Chemistry Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Current Medicinal Chemistry